Variability in gamma-ray sources by Morris, P

Interaction Between Maintenance Steroid Dose and the Risk/Benefit of Steroid Avoidance and Withdrawal Regimens Following Renal Transplantation by Knight, S, Morris, P

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review by Knight, S, Morris, P

The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review by Knight, S, Morris, P

Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis by Knight, S, Morris, P

Studies into the construction of low trafficked roads in the city of Salisbury, South Australia / by 209603 Morris, P. O.

Investigations at Bankstown, New South Wales/ by 209603 Morris, P. O.

Compaction, a review/ by 209603 Morris, P. O.

Divided government / by 350818 Fiorina, Morris P.

Thirty years after Jensen’s prediction: is private equity a superior form of ownership? by Morris, P, Phalippou, L

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. by Knight, SR, Morris, P

Immunological tolerance and transplantation - Preface by Morris, P, Wood, K

Azathioprine and Steroids by Knight, SR, Morris, P

Giovanna Zangrandi by Morris, P, Penelope Morris

Help in the design and reporting of randomized controlled trials: a collaboration between ESOT and CET towards a knowledge centre for European transplantations by Morris, P, Ploeg, R

Steroid avoidance or withdrawal in renal transplantation. by Knight, SR, Morris, P

Philosophical Transactions of the Royal Society of London Series B: Preface by Morris, P, Wood, K

In response to: Benefit of neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction. by Knight, SR, Morris, P

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis by Currie, A, Knight, S, Morris, P

A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection by Macklin, P, Morris, P, Knight, S